Related Experiment Video

Updated: Jun 6, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

[Clinical, biochemical and molecular characteristics in 11 Czech children with tyrosinemia type I]

Alzbeta Vondrácková1, Markéta Tesarová, Martin Magner

  • 1Univerzita Karlova v Praze, lékarská fakulta, Klinika detského a dorostového lékarství VFN.

Casopis Lekaru Ceskych
|December 2, 2010
PubMed

Insights

Hereditary tyrosinemia type 1 (HT1) is a rare metabolic disorder. Early diagnosis and treatment, including diet and Orfadin, improve patient outcomes, but liver cancer remains a risk.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Context:

  • Hereditary tyrosinemia type 1 (HT1) is a severe autosomal recessive metabolic disorder.
  • It results from fumarylacetoacetate hydrolase deficiency, leading to liver and kidney damage and increased liver cancer risk.

Purpose:

  • To detail the clinical, biochemical, and molecular genetic findings in 11 Czech patients with HT1.
  • To analyze the disease course and treatment outcomes in this cohort.

Summary:

  • The study analyzed 11 Czech patients diagnosed with HT1 between 1982-2006.
  • Clinical manifestations included failure to thrive, liver failure, and rickets.
  • Biochemical findings showed elevated liver enzymes, tyrosine, succinylacetone, and in some, delta-aminolevulinic acid.
  • FAH gene mutation analysis identified three novel mutations.
  • Outcomes varied: 6 patients improved with diet and Orfadin, while 2 developed liver cancer requiring transplantation.
  • Three patients died from liver cancer or failure before 1988.

Impact:

  • Highlights the critical role of early diagnosis, ideally through newborn screening, for improving HT1 prognosis.
  • Emphasizes the utility of molecular-genetic analysis for prenatal diagnosis in families with HT1.
  • Identified novel FAH gene mutations, contributing to the genetic understanding of HT1.
Abstract

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry06:53

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry

Published on: November 23, 2011

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...